Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Sales | 2,778,900 | 2,775,000 | 2,694,000 | 2,852,600 | 3,376,100 |
| Cost of Goods | 511,800 | 459,700 | 478,100 | 490,700 | 449,100 |
| Gross Profit | 2,267,100 | 2,315,300 | 2,215,900 | 2,361,899 | 2,927,000 |
| Operating Expenses | 1,473,900 | 1,830,300 | 1,242,100 | 2,195,900 | 1,840,700 |
| Operating Income | 794,000 | 485,700 | 973,900 | 166,699 | 1,086,400 |
| Other Income | -501,800 | 130,700 | -525,100 | 204,201 | -141,700 |
| Pre-tax Income | 292,200 | 616,400 | 448,800 | 370,900 | 944,700 |
| Income Tax | -25,900 | -409,100 | 44,200 | 13,400 | 240,800 |
| Net Income Continuous | 318,100 | 1,025,500 | 404,600 | 357,500 | 703,900 |
| Minority Interests | -11,100 | 577,000 | -5,600 | -400 | 2,400 |
| Net Income | $329,200 | $448,500 | $410,200 | $357,900 | $701,500 |
| EPS Basic Total Ops | 2.22 | 3.00 | 2.70 | 2.69 | 4.47 |
| EPS Basic Continuous Ops | 2.15 | 6.85 | 2.66 | 2.69 | 4.49 |
| EPS Diluted Total Ops | 2.22 | 2.99 | 2.69 | 2.67 | 4.46 |
| EPS Diluted Continuous Ops | 2.14 | 6.83 | 2.66 | 2.67 | 4.48 |
| EBITDA(a) | $970,600 | $1,144,500 | $1,120,800 | $257,100 | $1,220,400 |